Cardiogoniometry (CGM) for Early Diagnosis of Acute Coronary Syndromes (ACS)
CGM@ACS
Cardiogoniometry Zur Früherkennung Akuter Myokardischämien Bei ACS-Symptomatik
1 other identifier
interventional
249
0 countries
N/A
Brief Summary
Aims of the study: Patients in a Chest Pain Unit (CPU) are examined to clarify if the cause of pain is cardiac or not. To identify patients with ST-elevation and other electrocardiogram (ECG) modifications a normal 12-lead ECG is used. The diagnosis non-st-elevation myocardial infarction is determined with the help of the ischemic marker Troponin. However, Troponin levels are elevated earliest 3 to 4 hours after the ischemic event, so that a negative Troponin result at the time of hospital admission is insufficient. Thus the guidelines of the German Society of Cardiology demand a second measurement after 6 to 12 hours. In rare cases false positive Troponin levels have been reported (e.g. in patients with renal insufficiency). The aim of this study is to determine if in the early phase of diagnostic assessment cardiogoniometry can improve differentiation between patients with cardiac (ischemic) emergency and patients with non-cardiac (non-ischemic) cause of pain. Furthermore it will be evaluated if cardiogoniometry is capable to diagnose patients with non-ST-elevation myocardial infarction (NSTEMI) to the same extent as Troponin. This could avoid time loss until a possibly necessary catheter intervention ("fast track"). To clarify these questions the result of the cardiogoniometry will be compared with the leading diagnosis of the Chest Pain Unit, the diagnosis at hospital discharge as well as with the angiographic findings (as a gold standard). Therefore the performance of cardiac catheterization within 72 hours after start of symptoms is a mandatory inclusion criterion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2009
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 11, 2011
CompletedFirst Posted
Study publicly available on registry
April 5, 2011
CompletedApril 5, 2011
April 1, 2011
10 months
February 11, 2011
April 1, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference between cardiogoniometry finding and leading diagnoses of chest pain unit, coronary angiography, and at discharge in assessing the origin of chest pain
Aim is to examine if cardiogoniometry can provide additional information for the decision to perform a diagnostic coronary angiography and if so, which additional value it has. To assess the value of cardiogoniometry its results are compared with the leading diagnosis of the Chest Pain Unit, the diagnosis at hospital discharge as well as with the angiographic findings (as a gold standard).
72 hours
Interventions
In the course of the project a cardiogoniometry will be carried out during the ambulant or residential hospitalization before the coronary angiography.
Eligibility Criteria
You may qualify if:
- Age \> 18 years
- thoracic pain, or pain radiating to neck or arm, or acute dyspnoea
- coronary angiography within 72 hours after start of symptoms
You may not qualify if:
- ST elevation myocardial infarction
- hemodynamically unstable patients, provided that the application of CGM may lead to an unacceptable delay in diagnosis and therapy
- lack of blood samples for troponin determination at admission
- patients with cardiac pacemaker
- cardiogenic shock
- tachycardia (HR \> 100)
- \> 50% extra systoles
- branch block
- atrial fibrillation
- no informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jochen Senges, MD
Stiftung Institut fuer Herzinfarktfoschung
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 11, 2011
First Posted
April 5, 2011
Study Start
June 1, 2009
Primary Completion
April 1, 2010
Study Completion
May 1, 2010
Last Updated
April 5, 2011
Record last verified: 2011-04